Cargando…
Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809829/ https://www.ncbi.nlm.nih.gov/pubmed/33451318 http://dx.doi.org/10.1186/s13195-021-00770-2 |
| _version_ | 1783637194827628544 |
|---|---|
| author | Stockmann, Julia Verberk, Inge M. W. Timmesfeld, Nina Denz, Robin Budde, Brian Lange-Leifhelm, Julia Scheltens, Philip van der Flier, Wiesje M. Nabers, Andreas Teunissen, Charlotte E. Gerwert, Klaus |
| author_facet | Stockmann, Julia Verberk, Inge M. W. Timmesfeld, Nina Denz, Robin Budde, Brian Lange-Leifhelm, Julia Scheltens, Philip van der Flier, Wiesje M. Nabers, Andreas Teunissen, Charlotte E. Gerwert, Klaus |
| author_sort | Stockmann, Julia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7809829 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78098292021-01-18 Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline Stockmann, Julia Verberk, Inge M. W. Timmesfeld, Nina Denz, Robin Budde, Brian Lange-Leifhelm, Julia Scheltens, Philip van der Flier, Wiesje M. Nabers, Andreas Teunissen, Charlotte E. Gerwert, Klaus Alzheimers Res Ther Correction BioMed Central 2021-01-15 /pmc/articles/PMC7809829/ /pubmed/33451318 http://dx.doi.org/10.1186/s13195-021-00770-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Stockmann, Julia Verberk, Inge M. W. Timmesfeld, Nina Denz, Robin Budde, Brian Lange-Leifhelm, Julia Scheltens, Philip van der Flier, Wiesje M. Nabers, Andreas Teunissen, Charlotte E. Gerwert, Klaus Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title | Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title_full | Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title_fullStr | Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title_full_unstemmed | Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title_short | Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline |
| title_sort | correction to: amyloid-β misfolding as a plasma biomarker indicates risk for future clinical alzheimer’s disease in individuals with subjective cognitive decline |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809829/ https://www.ncbi.nlm.nih.gov/pubmed/33451318 http://dx.doi.org/10.1186/s13195-021-00770-2 |
| work_keys_str_mv | AT stockmannjulia correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT verberkingemw correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT timmesfeldnina correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT denzrobin correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT buddebrian correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT langeleifhelmjulia correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT scheltensphilip correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT vanderflierwiesjem correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT nabersandreas correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT teunissencharlottee correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline AT gerwertklaus correctiontoamyloidbmisfoldingasaplasmabiomarkerindicatesriskforfutureclinicalalzheimersdiseaseinindividualswithsubjectivecognitivedecline |